Top Page
Tate & Lyle (TATE) vs. S&P 500 (SPY)
Tate & Lyle Business Overview & Revenue Model
Tate & Lyle Financial Statement Overview
| Breakdown | ||||
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|
| Income Statement | Total Revenue | |||
| 1.65B | 1.75B | 1.38B | 1.21B | 2.88B | Gross Profit |
| 495.00M | 496.00M | 339.00M | 303.00M | 892.00M | EBIT |
| 234.00M | 226.00M | 166.00M | 157.00M | 317.00M | EBITDA |
| 345.00M | 300.00M | 145.00M | 209.00M | 473.00M | Net Income Common Stockholders |
| 188.00M | 190.00M | 236.00M | 253.00M | 245.00M |
| Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
| 437.00M | 475.00M | 110.00M | 371.00M | 271.00M | Total Assets |
| 2.28B | 2.51B | 3.25B | 2.97B | 2.85B | Total Debt |
| 590.00M | 713.00M | 679.00M | 788.00M | 722.00M | Net Debt |
| 153.00M | 238.00M | 569.00M | 417.00M | 451.00M | Total Liabilities |
| 1.04B | 1.32B | 1.63B | 1.51B | 1.45B | Stockholders Equity |
| 1.24B | 1.19B | 1.62B | 1.45B | 1.40B |
| Cash Flow | Free Cash Flow | |||
| 98.00M | 40.00M | -11.00M | 222.00M | 259.00M | Operating Cash Flow |
| 208.00M | 118.00M | 137.00M | 374.00M | 425.00M | Investing Cash Flow |
| -20.00M | 783.00M | -147.00M | -210.00M | -169.00M | Financing Cash Flow |
| -215.00M | -598.00M | -247.00M | -29.00M | -273.00M |
Tate & Lyle Technical Analysis
Tate & Lyle Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | £1.57B | 14.36 | 8.48% | 0.95% | 5.90% | 11.24% | |
76 Outperform | £13.38B | 9.55 | 13.01% | 3.32% | 1.64% | 44.38% | |
66 Neutral | £2.40B | 12.95 | 15.19% | 3.54% | -11.03% | -2.05% | |
65 Neutral | £69.35B | 23.09 | 6.18% | 7.59% | -5.19% | ― | |
64 Neutral | $47.62B | 16.94 | 48.76% | 3.77% | -3.88% | -11.33% | |
63 Neutral | $20.85B | 13.27 | -10.88% | 7.48% | 1.13% | 11.50% |
Tate & Lyle Corporate Events
Black Creek Investment Management Inc., based in Toronto, Canada, has increased its voting rights in Tate & Lyle PLC to 3.024979% as of February 26, 2025. This acquisition signifies a slight increase from its previous holding of 2.999830%, highlighting Black Creek’s growing influence in the company. The shares are held by 12 separate funds and clients advised by Black Creek, which exercises voting rights on their behalf. This development may impact Tate & Lyle’s shareholder dynamics and strategic decisions moving forward.
Tate & Lyle PLC announced a transaction involving Sarah Kuijlaars, the Chief Financial Officer, who acquired 20,000 ordinary shares at £5.645 each, totaling £112,900. This transaction, conducted on the London Stock Exchange, increases Kuijlaars’ total holdings to 40,000 shares, reflecting confidence in the company’s future prospects and potentially influencing stakeholder perceptions of its market stability.
Tate & Lyle PLC has applied for a block listing of 275,000 ordinary shares to be admitted to the Official List of the UK Listing Authority and traded on the London Stock Exchange. This move, related to the company’s Sharesave Plans, is expected to enhance the company’s liquidity and provide additional opportunities for employee investment.
Tate & Lyle PLC announced that Glenn Fish, a non-executive director, has acquired 1,000 American Depositary Receipts (ADRs) in the company, each representing four ordinary shares. This transaction reflects Fish’s growing interest in Tate & Lyle, totaling 3,960.4 ADRs equivalent to 15,841.6 shares. The transaction, conducted on the OTCQX exchange, underscores the company’s compliance with the Market Abuse Regulation and highlights potential confidence in the company’s prospects by its managerial personnel.
Tate & Lyle has reported a solid operating performance for the quarter ending December 2024, marked by volume and EBITDA growth, despite a 4% revenue decline due to input cost deflation. The acquisition and integration of CP Kelco are progressing well, with expected synergies reinforcing the company’s growth-focused strategy. This strategic move enhances Tate & Lyle’s market position, particularly in the mouthfeel segment, and supports their long-term goals of profitable volume growth and strong cash flow amidst geopolitical uncertainties and pricing pressures.
Tate & Lyle PLC announced changes in the non-executive directorships of its CEO, Nick Hampton. He will retire from his role at Great Portland Estates PLC, effective 3 April 2025, and join Severn Trent PLC as a non-executive director on 4 April 2025. Hampton will also take on significant committee roles and assume the position of Senior Independent Director from 1 May 2025. These changes are likely to influence the strategic direction and governance of Tate & Lyle, potentially impacting its market positioning and operational strategies.
Tate & Lyle PLC has announced its issued share capital as of February 3, 2025, consisting of 476,724,221 ordinary shares, including 31,294,579 held in Treasury which do not carry voting rights. This results in a total of 445,429,642 voting rights in the company, a figure shareholders can use for calculating their interest notifications under the Disclosure Guidance and Transparency Rules.
Tate & Lyle PLC announced a multi-tranche debt offering totaling US$300 million and €275 million to refinance a bridge facility used for the acquisition of CP Kelco and for general corporate purposes. The debt issuance, which was significantly oversubscribed, is part of the company’s strategy to secure attractive long-term interest rates and maintain a balanced fixed/floating debt mix, thus extending their debt maturity profile.
Tate & Lyle PLC has completed a non-discretionary share buyback program, purchasing 31,294,579 ordinary shares at a total value of approximately £215 million. This buyback is part of their broader strategy to enhance shareholder value, and following this transaction, the company has 445,429,642 ordinary shares in issue. This move reflects Tate & Lyle’s confidence in its growth prospects and financial stability, potentially strengthening its market position and returning value to stakeholders.
Tate & Lyle announced the purchase of 181,802 of its ordinary shares as part of a share buyback program initiated in June 2024. The shares were acquired at an average price of £6.39 and will be held in treasury, reflecting the company’s strategy to enhance shareholder value and optimize capital structure.
Tate & Lyle PLC has executed a share buyback transaction, purchasing 210,369 ordinary shares as part of its ongoing share buyback program initially announced in June 2024. The repurchased shares, acquired at a volume-weighted average price of £6.39 per share, will be held in treasury. This move reflects the company’s strategic decision to manage its capital structure and potentially enhance shareholder value.
Tate & Lyle PLC has reported a transaction involving Glenn Fish, a non-executive director, who acquired 949 American Depositary Receipts (ADRs) on January 7, 2025. Each ADR represents an interest in four ordinary shares of the company. The transaction was conducted on the OTCQX exchange, with the total purchase amounting to $30,995.25, as part of regulatory compliance under the Market Abuse Regulation.
Tate & Lyle PLC announced the purchase of 197,605 of its ordinary shares as part of its ongoing share buyback program. The repurchased shares will be held in treasury, contributing to a total of 30,902,408 shares held in treasury, with the company having 445,821,813 shares in issue. This move is part of a strategic initiative aimed at enhancing shareholder value and optimizing the company’s capital structure.
Tate & Lyle PLC announced the repurchase of 151,202 of its ordinary shares as part of its ongoing share buyback programme. The shares were acquired at a volume-weighted average price of £6.48 each and will be held in treasury, impacting the total number of shares in circulation and potentially enhancing shareholder value.
Tate & Lyle PLC announced the resignation of Patricia Corsi, a non-executive director, effective from 31 March 2025, due to scheduling conflicts with her executive responsibilities. Patricia has been a director since May 2021 and served on the Remuneration and Nominations Committees. This change in the board may influence the company’s governance dynamics, potentially affecting its strategic direction and stakeholder relations.
Tate & Lyle PLC announced the purchase of 146,125 ordinary shares as part of its ongoing share buyback program initiated in June 2024. The shares were purchased at a volume-weighted average price of £6.55 per share and will be held in treasury. This transaction is part of Tate & Lyle’s strategy to optimize its capital structure and potentially enhance shareholder value.
Tate & Lyle PLC announced the repurchase of 208,612 of its ordinary shares as part of its ongoing share buyback program. These shares were purchased from Merrill Lynch International at a price range between £6.50 and £6.65 per share, and will be held in treasury, indicating a strategic move to manage capital and potentially enhance shareholder value.
Tate & Lyle PLC announced the current voting rights and share capital structure. As of January 2, 2025, the company has 476,724,221 ordinary shares, with a total of 446,525,357 voting rights available to shareholders. This update aids shareholders in determining their reporting obligations under relevant financial regulations.
Tate & Lyle PLC announced the repurchase of 190,922 of its ordinary shares from Merrill Lynch International as part of its ongoing share buyback programme. The repurchased shares will be held in treasury, bringing the total number of ordinary shares in treasury to 30,198,864, with 446,525,357 ordinary shares remaining in issue. This transaction, conducted on December 30, 2024, was carried out on various trading venues, including the London Stock Exchange, Chi-X, and BATS. The move is part of Tate & Lyle’s efforts to manage its capital structure effectively, potentially enhancing shareholder value through stock price support and reduced outstanding share count.
Tate & Lyle PLC announced the purchase of 176,790 of its ordinary shares as part of its ongoing share buyback program. This transaction is aimed at optimizing the company’s capital structure and returning value to shareholders. The repurchased shares will be held in treasury, leaving the company with 446,716,279 ordinary shares in issue, excluding treasury shares.
Tate & Lyle PLC has announced the repurchase of 194,331 of its ordinary shares as part of a previously declared share buyback program. The shares, purchased from Merrill Lynch International at an average price of £6.62 per share, will be held in the company’s treasury. This move is part of Tate & Lyle’s strategic financial management, likely aimed at optimizing its capital structure and potentially returning value to its shareholders.
Tate & Lyle PLC has executed a share buyback, repurchasing 190,585 of its ordinary shares from Merrill Lynch International as part of its ongoing programme announced in June 2024. The shares, bought at a volume-weighted average price of £6.69, will be held in treasury, leaving the company with 29,636,821 shares in treasury out of a total of 447,087,400 shares issued.
Tate & Lyle PLC has executed a purchase of 175,972 of its ordinary shares as part of a share buyback initiative, initially announced on 20 June 2024. The repurchased shares will be held in treasury, adjusting the company’s treasury holdings to 29,270,375 shares, with 447,453,846 shares remaining in circulation. This strategic move is part of Tate & Lyle’s efforts to manage its capital structure and return value to shareholders, potentially enhancing its market position and shareholder confidence.
Tate & Lyle PLC has announced the repurchase of 194,541 of its ordinary shares as part of its share buyback program initiated earlier in the year. The shares, acquired at prices ranging from £6.88 to £7.02, will be held in treasury, contributing to a total of 29,094,403 treasury shares. This strategic move is aimed at optimizing the company’s capital structure and returning value to shareholders, reflecting positively on its financial management strategies.
Tate & Lyle PLC announced a transaction involving the repurchase of 115,646 of its ordinary shares as part of an ongoing share buyback program. The shares were bought at prices ranging from £7.02 to £7.09, with an average price of £7.05 per share. This financial maneuver is a part of the company’s strategy to manage its capital structure efficiently, potentially enhancing shareholder value by reducing the number of shares in circulation.
Tate & Lyle announced the purchase of 147,113 ordinary shares as part of their ongoing share buyback program initiated in June 2024. This strategic move is likely to impact the company’s stock value by consolidating its treasury shares, which now total 28,784,216 while maintaining 447,940,005 shares in issue. The shares were acquired at a volume-weighted average price of £7.08, reflecting a commitment to enhance shareholder value.
Tate & Lyle has executed a share buyback transaction, purchasing 125,798 of its ordinary shares through Merrill Lynch International. This transaction is part of a previously announced share buyback program. The repurchased shares will be held in treasury, contributing to a total of 28,637,103 treasury shares, with 448,087,118 shares remaining in issue. This move is likely aimed at enhancing shareholder value and optimizing the company’s capital structure.
Tate & Lyle PLC has announced a transaction involving Glenn Fish, a non-executive director, who acquired 750 American Depositary Receipts (ADRs) at a price of $36.09 per ADR. This acquisition, conducted on the OTCQX exchange, reflects ongoing managerial investments in the company, potentially indicating confidence in its market positioning and future performance.
Tate & Lyle PLC has executed a share buyback transaction, purchasing 177,944 of its ordinary shares from Merrill Lynch International. These repurchased shares, acquired at prices ranging between £7.03 and £7.13 each, are to be held in treasury, reflecting the company’s ongoing commitment to optimizing its capital structure and delivering value to shareholders.
Tate & Lyle plc has announced the repurchase of 119,640 of its ordinary shares as part of its ongoing share buyback programme, which was initially announced in June 2024. The shares were purchased at a volume weighted average price of £7.05 per share and will be held in treasury. This move may influence the company’s financial structure by reducing the number of shares in circulation, potentially increasing shareholder value.
Tate & Lyle has repurchased 219,042 of its own shares as part of its ongoing share buyback program, with shares being bought at an average price of £7.05 each. This move is part of the company’s strategic efforts to enhance shareholder value by holding these shares in treasury, bringing the total number of treasury shares to over 28 million.
Tate & Lyle has repurchased 180,168 of its ordinary shares as part of its ongoing share buyback program, with prices ranging from £7.09 to £7.18 per share. The repurchased shares will be held in treasury, contributing to the company’s 27,994,679 shares currently in treasury. This move is part of Tate & Lyle’s strategy to enhance shareholder value and manage its capital structure effectively.
Tate & Lyle has repurchased 209,243 of its ordinary shares at an average price of £7.12 per share as part of its ongoing share buyback program. These shares are now held in treasury, with the company having a total of 27,814,511 shares in treasury and 448,909,710 shares outstanding. This move is part of Tate & Lyle’s strategy to manage capital effectively and enhance shareholder value.
Tate & Lyle PLC has granted stock options to key executives under its Sharesave Plan 2020, providing an opportunity for Chief Financial Officer Sarah Kuijlaars and CEO Nick Hampton to purchase shares at 609 pence each. This move reflects the company’s ongoing strategy to align management interests with shareholder value. Investors may view these options as a signal of confidence in the company’s future performance.